Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Sales | 12,092 | 16,585 | 15,159 | 18,467 | 30,676 |
| Gross Profit | 12,092 | 16,585 | 15,159 | 18,467 | 30,676 |
| Operating Expenses | 60,632 | 61,804 | 60,493 | 58,479 | 57,441 |
| Operating Income | -48,540 | -45,219 | -45,334 | -40,012 | -26,765 |
| Other Income | 4,084 | 3,791 | 3,378 | 3,030 | 2,488 |
| Pre-tax Income | -44,456 | -41,428 | -41,956 | -36,982 | -24,277 |
| Income Tax | 90 | 90 | N/A | N/A | N/A |
| Net Income Continuous | -44,546 | -41,518 | -41,956 | -36,982 | -24,277 |
| Net Income | $-44,546 | $-41,518 | $-41,956 | $-36,982 | $-24,277 |
| EPS Basic Total Ops | -0.71 | -0.76 | -0.77 | -0.68 | -0.45 |
| EPS Basic Continuous Ops | -0.71 | -0.76 | -0.77 | -0.68 | -0.45 |
| EPS Diluted Total Ops | -0.71 | -0.76 | -0.77 | -0.68 | -0.45 |
| EPS Diluted Continuous Ops | -0.71 | -0.76 | -0.77 | -0.68 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.76 | -0.77 | N/A | N/A |
| EBITDA(a) | $-44,449 | $-41,331 | $-43,545 | $-38,273 | $-24,422 |